NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.
Publication
, Journal Article
Vohra-Miller, S; Schwartz, IS
Published in: CMAJ
September 12, 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CMAJ
DOI
EISSN
1488-2329
Publication Date
September 12, 2022
Volume
194
Issue
35
Start / End Page
E1214
Location
Canada
Related Subject Headings
- Viral Vaccines
- SARS-CoV-2
- Humans
- General & Internal Medicine
- COVID-19 Vaccines
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vohra-Miller, S., & Schwartz, I. S. (2022). NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ, 194(35), E1214. https://doi.org/10.1503/cmaj.220688
Vohra-Miller, Sabina, and Ilan S. Schwartz. “NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.” CMAJ 194, no. 35 (September 12, 2022): E1214. https://doi.org/10.1503/cmaj.220688.
Vohra-Miller S, Schwartz IS. NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ. 2022 Sep 12;194(35):E1214.
Vohra-Miller, Sabina, and Ilan S. Schwartz. “NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.” CMAJ, vol. 194, no. 35, Sept. 2022, p. E1214. Pubmed, doi:10.1503/cmaj.220688.
Vohra-Miller S, Schwartz IS. NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ. 2022 Sep 12;194(35):E1214.
Published In
CMAJ
DOI
EISSN
1488-2329
Publication Date
September 12, 2022
Volume
194
Issue
35
Start / End Page
E1214
Location
Canada
Related Subject Headings
- Viral Vaccines
- SARS-CoV-2
- Humans
- General & Internal Medicine
- COVID-19 Vaccines
- COVID-19
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences